AstraZeneca PLC (AZN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:49PM EDT. Market open.
| Previous close | 66.74 |
| Open | 67.05 |
| Bid | 66.62 x 900 |
| Ask | 66.63 x 900 |
| Day's range | 66.33 - 67.36 |
| 52-week range | 53.63 - 71.70 |
| Volume | |
| Avg. volume | 6,314,388 |
| Market cap | 206.594B |
| Beta (5Y monthly) | 0.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.36 |
| Earnings date | N/A |
| Forward dividend & yield | 1.45 (2.18%) |
| Ex-dividend date | 11 Aug 2022 |
| 1y target est | 73.38 |
- Zacks
Merck (MRK) Enters Into Circular RNA Collaboration With Orna
Merck (MRK) is set to make an upfront payment of $150 million to Orna for rights to the latter's circular RNA technology to make vaccines and therapeutics for infectious disease and oncology.
- Financial Times
AstraZeneca sues former executive over move to rival GSK
Pharma group alleges breach of non-compete agreement to delay start date of departing business development official
- Zacks
AstraZeneca's (AZN) Lynparza sNDA Gets FDA Priority Tag
FDA grants priority review to AstraZeneca (AZN) and Merck's (MRK) Lynparza as a combination therapy for patients with metastatic castration-resistant prostate cancer.
© 2022 Yahoo. All rights reserved.
